| 3.27 0.56 (20.66%) | 11-21 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 5.17 | 1-year : | 6.51 |
| Resists | First : | 4.43 | Second : | 5.57 |
| Pivot price | 3.8  |
|||
| Supports | First : | 2.57 | Second : | 2.13 |
| MAs | MA(5) : | 3.05 |
MA(20) : | 4.13 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | -0.8 |
Signal : | 0 |
| %K %D | K(14,3) : | 14.1 |
D(3) : | 8.5 |
| RSI | RSI(14): 35.9 |
|||
| 52-week | High : | 26.5 | Low : | 2.57 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ TTRX ] has closed above bottom band by 26.6%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 3.37 - 3.39 | 3.39 - 3.41 |
| Low: | 2.56 - 2.58 | 2.58 - 2.6 |
| Close: | 3.23 - 3.27 | 3.27 - 3.31 |
Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. Global Health Solutions, Inc. was incorporated in 2015 and is based in Westlake Village, California.
Mon, 17 Nov 2025
Zuraiz Chaudhary buys Turn Therapeutics (TTRX) shares worth $9,050 - Investing.com
Thu, 13 Nov 2025
Turn Therapeutics (NASDAQ: TTRX) posts Q3 net loss $1.90M; inks Medline license - Stock Titan
Thu, 13 Nov 2025
Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewswire
Tue, 04 Nov 2025
Turn Therapeutics appoints Andrew Scott as VP of Corporate Communications - Investing.com
Sun, 12 Oct 2025
TTRX Stock Price and Chart — NASDAQ:TTRX - TradingView
Thu, 09 Oct 2025
Turn Therapeutics Shares Skyrocket 134% After Hours Following Nasdaq Debut - Benzinga
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 28 (M) |
| Held by Insiders | 9.56e+006 (%) |
| Held by Institutions | 64.2 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -3.94e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -78.7 % |
| Return on Equity (ttm) | -2 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.1 |
| Qtrly Earnings Growth | -0.1 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 127100 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|